Allan Hildesheim

1990–2025 年に発表

199
論文数
31,467
被引用数
108
h 指数
187
i10 指数

被引用数

Allan Hildesheim の年別被引用数1991 年: 被引用 1 件1992 年: 被引用 3 件1993 年: 被引用 6 件1994 年: 被引用 16 件1995 年: 被引用 36 件1996 年: 被引用 55 件1997 年: 被引用 71 件1998 年: 被引用 47 件1999 年: 被引用 89 件2000 年: 被引用 148 件2001 年: 被引用 163 件2002 年: 被引用 217 件2003 年: 被引用 260 件2004 年: 被引用 227 件2005 年: 被引用 297 件2006 年: 被引用 300 件2007 年: 被引用 279 件2008 年: 被引用 358 件2009 年: 被引用 262 件2010 年: 被引用 259 件2011 年: 被引用 274 件2012 年: 被引用 281 件2013 年: 被引用 204 件2014 年: 被引用 217 件2015 年: 被引用 246 件2016 年: 被引用 191 件2017 年: 被引用 161 件2018 年: 被引用 184 件2019 年: 被引用 754 件2020 年: 被引用 644 件2021 年: 被引用 627 件2022 年: 被引用 447 件2023 年: 被引用 357 件2024 年: 被引用 624 件2025 年: 被引用 284 件2026 年: 被引用 5 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,688 件、この内訳の 27.1%中国: 引用元論文 860 件、この内訳の 8.7%イギリス: 引用元論文 631 件、この内訳の 6.4%フランス: 引用元論文 465 件、この内訳の 4.7%ドイツ: 引用元論文 380 件、この内訳の 3.8%カナダ: 引用元論文 336 件、この内訳の 3.4%イタリア: 引用元論文 300 件、この内訳の 3%オランダ: 引用元論文 288 件、この内訳の 2.9%オーストラリア: 引用元論文 246 件、この内訳の 2.5%スペイン: 引用元論文 230 件、この内訳の 2.3%インド: 引用元論文 204 件、この内訳の 2%スウェーデン: 引用元論文 192 件、この内訳の 1.9%
0%27.1%その他 31.3%

分野

  • Medicine74.2%
  • Biochemistry, Genetics and Molecular Biology14.3%
  • Immunology and Microbiology6.1%
  • Computer Science0.8%
  • Neuroscience0.7%
  • Environmental Science0.7%
  • その他3.2%

トピック

  • Cervical Cancer and HPV Research16.5%
  • Head and Neck Cancer Studies5.7%
  • Reproductive tract infections research3.7%
  • Genital Health and Disease3.5%
  • Hepatitis B Virus Studies3.3%
  • Endometrial and Cervical Cancer Treatments3.2%
  • その他64.1%

共著者

全論文

検索で開く
  1. Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT Trial

    著者: , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 被引用: 205

  2. Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections

    著者: , , , , , , , , - JNCI Journal of the National Cancer Institute 2008 被引用: 551

  3. Comparing one dose of HPV vaccine in girls aged 9–14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , - The Lancet Global Health 2022 被引用: 69

  4. Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark Schiffman, John T. Schiller, Mark E. Sherman, Lígia A. Pinto, Troy J. Kemp, Mary Sidawy, Wim Quint, Leen‐Jan van Doorn, Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler - The Lancet Oncology 2020 被引用: 130

  5. Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler - The Lancet Oncology 2022 被引用: 52

  6. Association of circulating inflammation proteins and gallstone disease

    著者: , , , , , , , , , , , , - Journal of Gastroenterology and Hepatology 2018 被引用: 90

  7. Human Papillomavirus Infection with Multiple Types: Pattern of Coinfection and Risk of Cervical Disease

    著者: , , , , , , , , , , , , - The Journal of Infectious Diseases 2011 被引用: 324

  8. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert D. Burk, Mark Schiffman - Cell 2017 被引用: 306

  9. Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials

    著者: , , , , , , , , , - The Lancet Oncology 2015 被引用: 303

  10. Longitudinal Study of Human Papillomavirus Persistence and Cervical Intraepithelial Neoplasia Grade 2/3: Critical Role of Duration of Infection

    著者: , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2010 被引用: 381

  11. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aurelio Barricarte, Anne Tjønneland, Carlotta Sacerdote, Antonia Trichopoulou, Roel Vermeulen, Wen‐Yi Huang, Neal D. Freedman, Paul E. Brennan, Tim Waterboer, Mattias Johansson - Annals of Oncology 2019 被引用: 91

  12. Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: The CVT Trial

    著者: , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 被引用: 88

  13. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2020 被引用: 86

  14. Cigarette Smoking and Variations in Systemic Immune and Inflammation Markers

    著者: , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2014 被引用: 319

  15. Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Su‐Mei Cao, Jun Ma, Anthony T.�C. Chan, K.C. Allen Chan, Allan Hildesheim - JNCI Journal of the National Cancer Institute 2023 被引用: 45

  16. Performance and Operational Feasibility of Epstein-Barr Virus–Based Screening for Detection of Nasopharyngeal Carcinoma: Direct Comparison of Two Alternative Approaches

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Chien‐Jen Chen, Allan Hildesheim, Ruth M. Pfeiffer, Zhiwei Liu, Kelly J. Yu, Cheng-Ping Wang, Tsung‐Lin Yang, Pei‐Jen Lou, Chun‐Nan Chen, Tseng‐Cheng Chen, Chih-Feng Lin, James Jer‐Min Jian, Skye Hongiun Cheng, Yu-Chen Tsai, Yih‐Lin Chung, Jia‐Shing Wu, Ming-Jiung Liu, Kuei-Kang Huang, Mei-Hua Tsou, Hsin-Hsuan Chen, Ching-Yuan Lin, Shyuang‐Der Terng, Fang-Yin Lin, Hsin-I Huang, Hung-Chun Cheng, Yung‐An Tsou, Chun-Hung Hua, Ming-Hsui Tsai, Yi‐Shing Leu, Jehn-Chuan Lee, Li-Jen Liao, Yen‐Liang Chang, Chuhsing Kate Hsiao, Ming‐Shiang Wu - Journal of Clinical Oncology 2023 被引用: 30

  17. Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

    著者: , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2011 被引用: 326

  18. Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies

    著者: , , , , , , , , , , , , , , , , , - Vaccine 2018 被引用: 151

  19. Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2018 被引用: 109

  20. molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Linda Struijk, Joel M. Palefsky, Teresa M. Darragh, Mark H. Stoler, Robert D. Burk - Nature Communications 2022 被引用: 64

  21. Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

    著者: , , , , , , , , , , , , - JAMA 2007 被引用: 662

  22. Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

    著者: , , , , , , , , , , , , , , , , - PLoS ONE 2013 被引用: 470

  23. Identification of a Novel, EBV-Based Antibody Risk Stratification Signature for Early Detection of Nasopharyngeal Carcinoma in Taiwan

    著者: , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2018 被引用: 80

  24. Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aimée R. Kreimer - Vaccine 2021 被引用: 40